Bayonier Timberlands LOG stock warned as risky dividend play
Malcolm Berko advises readers against buying Rayomer Timberlands LOG units, noting they are a declining asset with limited 2000 term and unlikely long term value. He cites a 6.32 per unit payout now, 17.9 percent yield, mostly return of principal, and potential cash flow decline in 1996. Readers urged to research before investing.
MENTIONED IN THIS ARTICLE
Rayomer Timberlands
Bayonier Timberlands S
Georgia
Florida
South Carolina
Washington State
LOG
Rayonier
RYN-840
Chucklehead
Rayomer
Malcolm Berko
Copley News Service
The
Herald-Journal
Berko
Syracuse Herald-Journal
P.O. Box
Boca Raton
Fla
Muddy Track Keeps Race Tension High On Slippery Turn
The field struggles on a muddy track with mounts pushing toward the home stretch. OTC leads by three lengths despite a $500 fishtail while Thirty-Year T-Bond holds second amid a $205 stumble. Blue Chip, Lipper Mutual, and Silver stay in close pursuit as others falter.
MENTIONED IN THIS ARTICLE
OTC
T-Bond
Blue Chip
Lipper Mutual
Silver
Ively
Lipper
Mutual
Pacoin
Eo boSe
Woduwadtys Goss
Vim A Mayers
Blue Chiacorape
Dow
Lipper Mutual West
International Funds
Love i Servicue
Sha CA
Shaputa
Morningstar notes dollar bias in bond fund hedges
Morningstar researchers find most international bond funds hedge by buying dollars and selling other currencies, linking dollar exposure to fund performance. They cite Benham European Bond and T Rowe Price International Bond as good examples, while funds like Prudential GNMA rebrand and Lindner Fund rename. Investors can call (800) 544-5670 for guidance.
MENTIONED IN THIS ARTICLE
Morningstar Inc
Chicago
Morningstar
Benham European Bond
T. Rowe Price International Bond
Prudential Gnma
Prudential
Fidelity Investments
Lindner Fund
Lindner Growth
Noven patch stock seen as high risk high reward
Noven Pharmaceuticals stock carries high risk with potential upside as its estrogen patch Vivelle nears US launch. The firm faces years of losses but could turn profitable as sales grow and new products reach market, with an 18 month upside of about 50 percent for investors willing to tolerate risk.
MENTIONED IN THIS ARTICLE
Noven Pharmaceuticals
Noven
Europe
United States
Estraderm
Noyén
Danka Business Systems
DANKY
Danka
Canada
Britain
U.S
Dankaas
Infotec Europe
Also Mentioned on This Page
Walter Cronkite
CBS News
Kay Gregory
S. Denice Jones
Judy Lehigh
Maureen Nosik
Lee Schrader
Mary Ann Circe
Carolee Dewey
Donald M. Moo
Amy Vanglish
Kathy Barany
Glynn English
David A. Farrell
J. Donald Herring
Janet N. Keown
William Kwiadowski
John Longtin
Mary Lu Moriarty
David C. Pease
Jacqueline M. Robinson
John M. Sabol
Silvia Loos-Kazel
Christine A. Town
Brian L. Winer
Rae Zollo
Central New York
Uman Resources
Michael Hill
Betty Ketchum
Ann Lesniak
Joseph Oppedisano
Larry Taylor
Human Resources
Garry Coutts
James Holland
Michael Slade
Audrey Wolniak
Central New York Area
Beth L. Burgmaster
Charles J. Fairchild
Matt D. FitzGibbons
Nancy B. Holden
Kevin J. Kersey
Adora Lester
Manuel Mena
SHRM
CNY
OnCenter
Atat
At&t
PaineWebber
Warren Street
Syracuse
Lember Hipc
Pencu H
Rayomier Timberlands
Aelas
Pei
the N
Lipper Mutual Funds
Lipper Internation
EE U.S. Savings
G.T. Global Goverment Income
Scudder International Bond
Putnam Global Goverment Income
Bowroe
Morningater Inc
Invesco
Small Co
Fidel
Vemeneweene
Thee
NY Times News Servi
By Steve Halpern
Knight-Ridder Newspapers
Eckerd Nyse
ECK
Eckerd
Drugstone
Sunbelt
Elizabeth Bramwell
Bramwell Capital Management
Steve Halpern
Dick Davis